PD-154 An open-label, multi centre phase II, non-comparative trial of ZD1839 monotherapy in chemotherapy-naive patients with stage IV or stage III non-operable non-small cell lung cancer (NSCLC)
Reck, M., Buchholz, E., Gahlemann, C., Gatzemeier, U., Manegold, C.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80487-8
Date:
July, 2005
File:
PDF, 281 KB
english, 2005